Literature DB >> 3323893

[Extracorporeal membrane oxygenation (ECMO). A treatment alternative for newborn infants with severe respiratory disorder].

W Kachel1, D Arnold, W Rettwitz, P Lasch, W Brands.   

Abstract

Extracorporeal Membrane Oxygenation (ECMO) is a promising alternative for newborns with critical respiratory disease, where conservative management is no longer sufficient. - Indications for ECMO include mainly the diagnoses Persisting Pulmonary Hypertension (PPHN), Meconium-Aspiration and Congenital Diaphragmatic Hernia. In patients with a mortality-prognosis of 80-100% ECMO will raise survival rates to about 80% with a good general developmental prognosis. Conditions, trainee programs, and experiences up to the first clinical application of ECMO are reported.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323893

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd        ISSN: 0026-9298            Impact factor:   0.323


  3 in total

1.  High-quality logistical concept for interhospital transport is crucial.

Authors:  Jochen Hinkelbein; Oliver Spelten; Christian Mey
Journal:  Dtsch Arztebl Int       Date:  2013-07       Impact factor: 5.594

2.  High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn.

Authors:  V Varnholt; P Lasch; G Suske; W Kachel; W Brands
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

3.  Outcomes and factors associated with early mortality in pediatric and neonatal patients requiring extracorporeal membrane oxygenation for heart and lung failure.

Authors:  Farid Azizov; Julia Merkle; Javid Fatullayev; Kaveh Eghbalzadeh; Ilija Djordjevic; Carolyn Weber; Sergey Saenko; Axel Kroener; Mohamed Zeriouh; Anton Sabashnikov; Gerardus Bennink; Thorsten Wahlers
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.